CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival

Noa Gross Even-Zohar*, Marjorie Pick, Liron Hofstetter, Adir Shaulov, Boaz Nachmias, Eyal Lebel, Moshe E. Gatt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology